This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Isogai, E. Articles by Takeshi, K. Search for Related Content PubMed PubMed Citation Articles by Isogai, E. Articles by Takeshi, K.

 Previous Article  |  Next Article 

Infect. Immun., Jan 1998, 197-202, Vol 66, No. 1
Copyright © 1998, American Society for Microbiology

Role of tumor necrosis factor alpha in gnotobiotic mice infected with an Escherichia coli O157:H7 strain

E Isogai, H Isogai, K Kimura, S Hayashi, T Kubota, N Fujii and K Takeshi
Department of Preventive Dentistry, School of Dentistry, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan. emikoisogai@msn.com

Gnotobiotic mice inoculated with an enterohemorrhagic Escherichia coli (EHEC) O157:H7 strain developed a flaccid paresis, usually culminating in death. The bacteria colonized feces at 10(9) to 10(10) CFU per g (inoculum size: 2.0 x 10(9) CFU/mouse), and Shiga-like toxins (SLTs) were detected in the feces. A microscopic examination of colons showed mild inflammatory cell infiltration, thinning of the intestinal wall, or necrotic foci. Necrosis of tubular cells was noted in these symptomatic mice. Microhemorrhage, thrombosis, and edematous changes of the brain were also seen. Inflammatory cytokines, tumor necrosis factor alpha (TNF-alpha), interleukin 1alpha (IL-1alpha), and IL-6, were detected in the kidney after EHEC infection, but not in the serum. In the brain, only TNF-alpha was detected. When 2.0 x 10(2) CFU of EHEC O157:H7 was fed to germ-free mice, the number of bacteria began to rise rapidly on day 1 and was maintained at 10(8)to 10(9) CFU/g of feces. SLTs were detected in the feces of the mice. However, the mice showed no histological changes and no cytokine responses, similar to what was found for controls. Treatment with TNF-alpha modified the clinical neural signs, histopathological changes, and cytokine responses; mice treated with TNF-alpha developed severe neurotoxic symptoms and had higher frequencies of systemic symptoms and glomerular pathology. Strong cytokine responses were seen in the kidney and brain. Serum cytokines were also detected in this group. In contrast, a TNF-alpha inhibitor (protease inhibitor) inhibited these responses, especially in the brain. However, local synthesis of the cytokines was observed in the kidney. Thus, TNF-alpha and the other proinflammatory cytokines could be important in modifying the disease caused by EHEC.

This article has been cited by other articles:

• Eaton, K. A., Friedman, D. I., Francis, G. J., Tyler, J. S., Young, V. B., Haeger, J., Abu-Ali, G., Whittam, T. S. (2008). Pathogenesis of Renal Disease Due to Enterohemorrhagic Escherichia coli in Germ-Free Mice. Infect. Immun. 76: 3054-3063 [Abstract] [Full Text]  
• Harrison, L. M., van Haaften, W. C. E., Tesh, V. L. (2004). Regulation of Proinflammatory Cytokine Expression by Shiga Toxin 1 and/or Lipopolysaccharides in the Human Monocytic Cell Line THP-1. Infect. Immun. 72: 2618-2627 [Abstract] [Full Text]  
• Dahan, S., Dalmasso, G., Imbert, V., Peyron, J.-F., Rampal, P., Czerucka, D. (2003). Saccharomyces boulardii Interferes with Enterohemorrhagic Escherichia coli-Induced Signaling Pathways in T84 Cells. Infect. Immun. 71: 766-773 [Abstract] [Full Text]  
• Eddy, A. A. (2002). Plasminogen activator inhibitor-1 and the kidney. Am. J. Physiol. Renal Physiol. 283: F209-F220 [Abstract] [Full Text]  
• Dahan, S., Busuttil, V., Imbert, V., Peyron, J.-F., Rampal, P., Czerucka, D. (2002). Enterohemorrhagic Escherichia coli Infection Induces Interleukin-8 Production via Activation of Mitogen-Activated Protein Kinases and the Transcription Factors NF-{kappa}B and AP-1 in T84 Cells. Infect. Immun. 70: 2304-2310 [Abstract] [Full Text]  
• Kirchgatterer, A., Weber, T., Hinterreiter, M., Knoflach, P., Allerberger, F. (2002). Haemorrhagic colitis due to Escherichia coli O103:H2 associated with infliximab therapy in a patient with rheumatoid arthritis. Rheumatology (Oxford) 41: 355-356 [Full Text]  
• Zhang, H.-M., Ou, Z.-L., Yamamoto, T. (2001). Anisodamine Inhibits Shiga Toxin Type 2-Mediated Tumor Necrosis Factor-{{alpha}} Production in Vitro and in Vivo. Exp. Biol. Med. 226: 597-604 [Abstract] [Full Text]  
• Ogawa, M., Shimizu, K., Nomoto, K., Takahashi, M., Watanuki, M., Tanaka, R., Tanaka, T., Hamabata, T., Yamasaki, S., Takeda, Y. (2001). Protective Effect of Lactobacillus casei Strain Shirota on Shiga Toxin-Producing Escherichia coli O157:H7 Infection in Infant Rabbits. Infect. Immun. 69: 1101-1108 [Abstract] [Full Text]  
• Kita, E., Yunou, Y., Kurioka, T., Harada, H., Yoshikawa, S., Mikasa, K., Higashi, N. (2000). Pathogenic Mechanism of Mouse Brain Damage Caused by Oral Infection with Shiga Toxin-Producing Escherichia coli O157:H7. Infect. Immun. 68: 1207-1214 [Abstract] [Full Text]